Characterization of the murine CD30 ligand (CD153) gene: Gene structure and expression

被引:5
作者
Goldie-Cregan, LC [1 ]
Croager, EJ [1 ]
Abraham, LJ [1 ]
机构
[1] Univ Western Australia, Sch Biomed & Clin Sci, Crawley, WA 6009, Australia
来源
TISSUE ANTIGENS | 2002年 / 60卷 / 02期
关键词
CD153; CD30; ligand; gene; lymphoma; murine; transcription;
D O I
10.1034/j.1399-0039.2002.600204.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD153 (CD30 ligand) has been described as a 40-kDa type II transmembrane glycoprotein belonging to the TNF superfamily and is expressed primarily by activated T cells, B cells and monocytes. In this study, we have determined that the murine CD153 gene consists of four exons, with three intervening introns, spaced over approximately 26 kb of genomic sequence. Sequence analysis of the murine CD153 promoter and 5 flanking region revealed the presence of a TATA box element immediately upstream of two tsp sites, together with putative binding motifs for a variety of lymphoid-specific transcription factors. 5 RACE analysis of LPS-stimulated RAW264.7 macrophage cDNA identified at least four transcriptional start sites for murine CD153, with two sites occurring downstream of the previously predicted translation initiation codon. Additionally, 5 RACE analysis identified multiple murine CD153 polyadenylation sites. Our results indicate that primary murine CD153 transcripts may vary from 26 kb to approximately 28 kb in length.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 30 条
[1]   Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice [J].
Amakawa, R ;
Hakem, A ;
Kundig, TM ;
Matsuyama, T ;
Simard, JJL ;
Timms, E ;
Wakeham, A ;
Mittruecker, HW ;
Griesser, H ;
Takimoto, H ;
Schmits, R ;
Shahinian, A ;
Ohashi, PS ;
Penninger, JM ;
Mak, TW .
CELL, 1996, 84 (04) :551-562
[2]   PCR AMPLIFICATION OF UP TO 35-KB DNA WITH HIGH-FIDELITY AND HIGH-YIELD FROM LAMBDA-BACTERIOPHAGE TEMPLATES [J].
BARNES, WM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) :2216-2220
[3]   Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD) [J].
Bengtsson, A ;
Holm, L ;
Back, O ;
Fransson, J ;
Scheynius, A .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (03) :533-537
[4]  
BISWAS P, 1995, IMMUNITY, V2, P587
[5]  
CALIGARISCAPPIO F, 1995, CLIN EXP RHEUMATOL, V13, P339
[6]   Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells [J].
Cerutti, A ;
Schaffer, A ;
Goodwin, RG ;
Shah, S ;
Zan, H ;
Ely, S ;
Casali, P .
JOURNAL OF IMMUNOLOGY, 2000, 165 (02) :786-794
[7]   EFFECTIVE AMPLIFICATION OF LONG TARGETS FROM CLONED INSERTS AND HUMAN GENOMIC DNA [J].
CHENG, S ;
FOCKLER, C ;
BARNES, WM ;
HIGUCHI, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) :5695-5699
[8]   CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: Evidence for a T helper 2-mediated condition [J].
Chilosi, M ;
Facchetti, F ;
Notarangelo, LD ;
Romagnani, S ;
DelPrete, G ;
Almerigogna, F ;
DeCarli, M ;
Pizzolo, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (02) :329-334
[9]   Characterisation of the human CD30 ligand gene structure [J].
Croager, EJ ;
Abraham, LJ .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1997, 1353 (03) :231-235
[10]   CD30, TH2 CYTOKINES AND HIV-INFECTION - A COMPLEX AND FASCINATING LINK [J].
DELPRETE, G ;
MAGGI, E ;
PIZZOLO, G ;
ROMAGNANI, S .
IMMUNOLOGY TODAY, 1995, 16 (02) :76-80